Definition and epidemiology
Lymphedema is the abnormal accumulation of protein-rich interstitial fluid due to impaired lymphatic transport capacity relative to lymphatic load. It most commonly affects the limbs but can involve the trunk, face, or genitalia.
Worldwide, secondary lymphedema from filariasis is the leading cause in endemic tropical regions, affecting an estimated 25 million people or more. In high-income countries, secondary lymphedema related to cancer treatment (especially breast cancer with axillary lymph node dissection or radiation) is the dominant cause, developing in roughly 15-25% of breast cancer survivors who undergo axillary intervention.
Primary lymphedema is rare, with an estimated prevalence on the order of 1 in 100,000, and is more often diagnosed in females. It can present at birth (Milroy disease), around puberty (lymphedema praecox, the most common primary form), or after age 35 (lymphedema tarda).
- Stemmer sign (unable to pinch skin fold at base of 2nd toe/finger) is specific for lymphedema, not venous edema
- Worldwide, filariasis (Wuchereria bancrofti) is the most common cause; in developed countries, cancer treatment is most common
- Milroy disease = autosomal dominant, VEGFR3/FLT4 mutation, congenital lower limb lymphedema
- Lymphoscintigraphy is the gold standard confirmatory imaging test
- Diuretics do NOT work for lymphedema because fluid is protein-rich, not simple volume overload
- First-line treatment is complete decongestive therapy: manual drainage + compression + exercise + skin care
- Stewart-Treves syndrome = lymphangiosarcoma arising in chronic lymphedema, classically postmastectomy
- Lymphedema praecox (Meige disease) is the most common primary form, presenting around puberty
Etiology and risk factors
Primary (congenital/hereditary)
- Milroy disease: autosomal dominant, mutations in VEGFR3 (FLT4), presents at birth, often bilateral lower limb
- Meige disease (lymphedema praecox): onset around puberty, most common primary form
- Associated syndromes: Turner syndrome, Noonan syndrome, lymphedema-distichiasis syndrome
Secondary (acquired) - much more common
- Cancer treatment: axillary or inguinal lymph node dissection, regional radiation therapy
- Infection: lymphatic filariasis (Wuchereria bancrofti) - leading global cause
- Recurrent cellulitis/erysipelas causing progressive lymphatic damage
- Trauma or surgery disrupting lymphatic channels
- Malignant obstruction by tumor or lymph node metastasis
- Chronic venous insufficiency (can lead to combined phlebolymphedema)
- Obesity (increasingly recognized as an independent risk factor and aggravating factor)
Risk factors for secondary lymphedema after cancer treatment include extent of lymph node dissection, use of radiation, postoperative infection, and higher body mass index.
Pathophysiology
Normally, the lymphatic system returns interstitial fluid, proteins, and immune cells to the venous circulation. Lymphedema develops when lymphatic transport capacity falls below the lymphatic load, either from reduced capacity (damaged or absent vessels/nodes) or increased load that overwhelms a normal system.
Protein-rich fluid accumulates in the interstitium, raising oncotic pressure and drawing in more fluid. Chronic stagnation triggers a fibroadipose tissue response: fibroblast proliferation, adipocyte hypertrophy, and collagen deposition cause progressive tissue fibrosis and thickening (unlike the readily mobile fluid of simple edema).
Stagnant protein-rich fluid also impairs local immune surveillance, predisposing to recurrent bacterial and fungal skin infections (cellulitis, lymphangitis), which further damage lymphatics and worsen the condition in a self-perpetuating cycle.
Clinical features
- Painless, slowly progressive limb swelling, often starting distally (fingers/toes) and progressing proximally
- Early stage: pitting edema that improves with elevation
- Late stage: non-pitting, woody, fibrotic swelling that does not improve with elevation
- Positive Stemmer sign: inability to pinch and lift a skin fold at the base of the second toe or finger - highly specific
- Thickened, hyperkeratotic, verrucous skin changes in chronic disease
- Recurrent episodes of cellulitis or lymphangitis
- Heaviness, discomfort, or restricted range of motion in the affected limb
- Papillomatosis and, in severe long-standing cases, elephantiasis
Staging (International Society of Lymphology)
| Stage | Features |
|---|---|
| 0 (latent) | Impaired transport but no visible swelling |
| I | Pitting edema, reversible with elevation |
| II | Non-pitting, fibrosis present, not fully reversible |
| III | Elephantiasis, severe fibrosis, skin changes |
Diagnosis
Diagnosis is largely clinical, based on history (prior surgery, radiation, infection, travel to filariasis-endemic areas) and examination findings.
- Stemmer sign: key bedside test, positive in lymphedema, typically negative in venous or lipedema
- Limb circumference or volume measurements to track progression and treatment response
- Lymphoscintigraphy: gold standard imaging study, shows delayed or absent lymphatic uptake and dermal backflow
- Duplex ultrasound: to exclude or identify concomitant venous insufficiency or DVT
- MRI or CT: can show the characteristic "honeycomb" pattern of skin and subcutaneous thickening, and helps exclude malignant obstruction
- Genetic testing: considered in suspected primary/hereditary lymphedema
- In endemic regions, blood smear or antigen testing for filariasis when clinically suspected
Differential diagnosis
- Chronic venous insufficiency: pitting edema, improves with elevation, Stemmer sign negative, skin changes include venous stasis dermatitis and ulcers near the medial malleolus
- Lipedema: bilateral, symmetric fat deposition sparing the feet, Stemmer sign negative, often in women, non-pitting but soft
- Deep vein thrombosis: acute unilateral swelling, pain, warmth; requires urgent ultrasound to exclude
- Heart failure/renal/hepatic disease: bilateral, pitting, systemic signs, responds to diuretics
- Cellulitis: acute, warm, erythematous, tender, often with fever
- Myxedema (hypothyroidism): generalized non-pitting edema with other hypothyroid features
Management
There is no cure for lymphedema; management focuses on reducing swelling, preventing complications, and improving quality of life. International guidelines (ISL, American Cancer Society, European consensus) converge on conservative therapy as first-line.
Complete decongestive therapy (CDT) - first-line
- Manual lymphatic drainage (specialized massage technique)
- Multilayer compression bandaging, followed by fitted compression garments for maintenance
- Therapeutic exercise of the affected limb
- Meticulous skin care and hygiene to prevent infection
Adjunctive measures
- Pneumatic compression devices for maintenance therapy
- Weight management, since obesity worsens outcomes
- Prompt treatment of cellulitis episodes with appropriate antibiotics; some patients with recurrent cellulitis are considered for prophylactic antibiotics
- Diethylcarbamazine or other antifilarial agents when filariasis is the underlying cause
Surgical options (refractory or advanced cases)
- Lymphaticovenous anastomosis (microsurgical, best in earlier stages)
- Vascularized lymph node transfer
- Debulking procedures (e.g., Charles procedure) for severe elephantiasis
Diuretics are not effective for lymphedema and are not recommended as primary therapy, since the problem is protein-rich fluid and lymphatic transport failure, not volume overload.
Complications and prognosis
- Recurrent cellulitis and lymphangitis, which can further damage lymphatics and worsen the edema
- Chronic skin changes: hyperkeratosis, papillomatosis, fibrosis
- Lymphangiosarcoma (Stewart-Treves syndrome): rare, aggressive malignancy arising in chronic longstanding lymphedema, classically after mastectomy with radiation
- Significant impact on mobility, body image, and quality of life
- Lymphedema is a chronic, generally lifelong condition; early diagnosis and consistent compression therapy significantly reduce progression and complication rates, but established fibrotic changes are not reversible
Think "CDT fixes LEGS": Compression, Decongestive manual drainage, Therapeutic exercise, and skin care — for Lymphedema of the Extremities, Genitals, and other sites; diuretics have no role.
Practice questions
1. A 54-year-old woman develops progressive right arm swelling 8 months after undergoing a mastectomy with axillary lymph node dissection and adjuvant radiation for breast cancer. On examination, the swelling is non-pitting and she is unable to pinch a skin fold at the base of her fingers. Which of the following best describes the underlying mechanism?
2. A 2-week-old female infant is noted to have bilateral painless swelling of both feet and lower legs since birth. There is a family history of similar swelling in the mother and maternal grandfather. Genetic testing reveals a mutation in the VEGFR3 (FLT4) gene. Which of the following is the most likely diagnosis?
3. A 61-year-old man with long-standing lower extremity lymphedema for 15 years presents with a rapidly enlarging, violaceous, nodular mass on his lower leg. Biopsy reveals a high-grade vascular sarcoma. Which of the following best describes this condition?
Frequently asked questions
What causes lymphedema?
Lymphedema is caused by impaired lymphatic drainage that lets protein-rich fluid build up in tissue. Worldwide, the leading cause is lymphatic filariasis (a parasitic infection), while in high-income countries the leading cause is cancer treatment, especially axillary lymph node dissection or radiation for breast cancer. Rarer primary forms result from inherited lymphatic malformations present from birth or puberty.
What are the first symptoms of lymphedema?
Early symptoms are often subtle: a feeling of heaviness, tightness, or mild swelling in a limb, usually starting at the fingers or toes and spreading proximally. In this early stage the swelling is pitting and improves with elevation. As it progresses, swelling becomes persistent, non-pitting, and the skin may thicken.
How is lymphedema diagnosed?
Diagnosis is mainly clinical, based on history of surgery, radiation, infection, or travel, combined with the Stemmer sign (inability to pinch a skin fold at the base of the toes or fingers). Lymphoscintigraphy is the gold standard imaging test to confirm impaired lymphatic flow, while ultrasound or MRI help exclude venous disease or malignant obstruction.
Is lymphedema curable?
Lymphedema is generally not curable but is manageable with lifelong treatment. Complete decongestive therapy, consisting of manual lymphatic drainage, compression bandaging, exercise, and skin care, can significantly reduce swelling and prevent complications. Surgical options like lymphaticovenous anastomosis may help select patients, but established fibrosis typically does not fully resolve.
Lymphedema vs chronic venous insufficiency — what is the difference?
Lymphedema involves protein-rich fluid from impaired lymphatic drainage, produces a positive Stemmer sign, and becomes non-pitting and fibrotic over time. Chronic venous insufficiency involves fluid from impaired venous return, remains pitting, improves with leg elevation, has a negative Stemmer sign, and typically shows venous stasis skin changes and ulcers near the medial ankle.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: Q82.0
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.